{"id":"W2782629081","doi":"10.1200/jco.2016.34.15_suppl.tps2604","title":"ROAR: a phase 2, open-label study in patients (pts) with BRAF V600E–mutated rare cancers to investigate the efficacy and safety of dabrafenib (D) and trametinib (T) combination therapy.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Trametinib; Oncology; Cancer; Melanoma; V600E; Gastroenterology; Cancer research; Mutation","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00143934,0.0001134385,0.0005250346,0.00004810784,0.00003701707,0.00001684733,0.0002443694,0.0001279479,0.000004652475],"category_scores_gemma":[0.001603466,0.00006031971,0.00003133421,0.00009797478,0.0002147288,0.00001117757,0.0001382319,0.0001648146,2.460797e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004613461,"about_ca_system_score_gemma":0.0006767709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007437476,"about_ca_topic_score_gemma":0.0005048417,"domain_scores_codex":[0.998202,0.0003531529,0.0009713098,0.0002125081,0.0001277286,0.0001333385],"domain_scores_gemma":[0.9978784,0.0007823583,0.0007411404,0.0001640637,0.0002601479,0.0001738303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04925665,0.01231784,0.2774762,0.00001017562,0.0004826296,0.00003245323,0.0007050903,0.00007741771,0.006500102,0.00007830793,0.001108262,0.6519548],"study_design_scores_gemma":[0.2135002,0.117283,0.6496419,0.0001168043,0.0001155704,0.00001691913,0.0002637072,0.00002587793,0.001925383,0.0001923692,0.01669478,0.0002234657],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966292,0.0002224265,0.00005275455,0.002165187,0.0001600792,0.0006875509,0.00002186871,8.513755e-7,0.00006011166],"genre_scores_gemma":[0.9972501,0.001282414,0.0003129508,0.001036503,0.00007278071,0.000009052717,0.000003752049,0.00001186766,0.00002056258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6517314,"threshold_uncertainty_score":0.2459767,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07249467770115313,"score_gpt":0.4216821714807678,"score_spread":0.3491874937796146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}